These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15348964)

  • 21. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 22. [Quicker thrombolytic treatment in stroke?].
    Johnsen SH
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2213. PubMed ID: 19898566
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke.
    Docagne F; Parcq J; Lijnen R; Ali C; Vivien D
    Stroke; 2015 Jan; 46(1):314-20. PubMed ID: 25395410
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
    Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
    J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific therapies for ischaemic stroke: rTPA and others.
    Toni D; Lorenzano S; Sacchetti ML; Fiorelli M; De Michele M; Principe M
    Neurol Sci; 2005 May; 26 Suppl 1():S26-8. PubMed ID: 15883686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolysis in strokes: time for the neurologist].
    Segura T
    Rev Neurol; 2007 Jun 1-15; 44(11):641-2. PubMed ID: 17557218
    [No Abstract]   [Full Text] [Related]  

  • 31. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing hypertension in patients with stroke. Are you prepared for labetalol infusion?
    Harrington C
    Crit Care Nurse; 2003 Jun; 23(3):30-8. PubMed ID: 12830778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Kurth T; Heuschmann PU; Walker AM; Berger K
    Neurology; 2007 Feb; 68(9):710; author reply 711. PubMed ID: 17325289
    [No Abstract]   [Full Text] [Related]  

  • 35. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Flaherty ML; Kissela B; Khatri P
    Neurology; 2007 Feb; 68(9):710-1; author reply 711. PubMed ID: 17328117
    [No Abstract]   [Full Text] [Related]  

  • 36. Stroke biomarkers: Can they help us to guide stroke thrombolysis?
    Montaner J
    Drug News Perspect; 2006 Nov; 19(9):523-32. PubMed ID: 17220957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soduko.
    Hughes T
    Pract Neurol; 2011 Dec; 11(6):375. PubMed ID: 22100953
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
    Padma V; Fisher M; Moonis M
    Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An ideal thrombolytic and antithrombotic agent?
    Matsuo O
    J Thromb Haemost; 2005 Oct; 3(10):2154-5. PubMed ID: 16194193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.